1. Home
  2. KMPR vs NVAX Comparison

KMPR vs NVAX Comparison

Compare KMPR & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kemper Corporation

KMPR

Kemper Corporation

HOLD

Current Price

$26.09

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.92

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KMPR
NVAX
Founded
1990
1987
Country
United States
United States
Employees
7400
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
KMPR
NVAX
Price
$26.09
$8.92
Analyst Decision
Hold
Hold
Analyst Count
5
9
Target Price
$47.67
$11.33
AVG Volume (30 Days)
1.1M
4.9M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
3.85%
N/A
EPS Growth
N/A
309.76
EPS
N/A
N/A
Revenue
N/A
$1,123,479,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.35
N/A
P/E Ratio
$14.38
N/A
Revenue Growth
N/A
64.69
52 Week Low
$22.69
$6.20
52 Week High
$64.96
$11.85

Technical Indicators

Market Signals
Indicator
KMPR
NVAX
Relative Strength Index (RSI) 48.05 44.77
Support Level $22.69 $7.94
Resistance Level $26.54 $9.02
Average True Range (ATR) 0.90 0.62
MACD 0.39 -0.08
Stochastic Oscillator 86.99 23.04

Price Performance

Historical Comparison
KMPR
NVAX

About KMPR Kemper Corporation

Kemper Corp is an insurance holding company that offers complementary insurance products through its subsidiaries, including personal and commercial automobile insurance to consumers in targeted markets and industries. Kemper also offers life and other insurance solutions based on the needs of its clients. The company offers its insurance products through a vast network of agents and brokers, mainly under the Kemper Auto and Kemper Life brands. It has two operating segments: Specialty Property & Casualty Insurance and Life Insurance. The majority of the company's revenue is generated from the Specialty Property & Casualty Insurance segment, whose principal products are specialty personal automobile and commercial automobile insurance. Geographically, it operates only in the United States.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: